Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Autor: Dijkmans AC; Centre for Human Drug Research, Leiden, 2333 CL, The Netherlands. annekedijkmans@hotmail.com.; Department of Medical Microbiology, Albert Schweitzer Hospital, Dordrecht, 3318 AT, The Netherlands. annekedijkmans@hotmail.com., Zacarías NVO; Centre for Human Drug Research, Leiden, 2333 CL, The Netherlands. n.v.ortiz.zacarias@lacdr.leidenuniv.nl., Burggraaf J; Centre for Human Drug Research, Leiden, 2333 CL, The Netherlands. kb@chdr.nl., Mouton JW; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, 6500 HB, The Netherlands. j.stevens@umcg.nl.; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, 3015 CN, The Netherlands. j.stevens@umcg.nl., Wilms EB; Hospital Pharmacy, The Hague Hospitals, The Hague, 2545 AB, The Netherlands. jwmouton@gmail.com., van Nieuwkoop C; Department of Internal Medicine, Haga Teaching Hospital, The Hague, 2566 MJ, The Netherlands. e.wilms@ahz.nl., Touw DJ; Groningen Research Institute for Asthma and COPD, Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, 9713 GZ, The Netherlands. c.vannieuwkoop@hagaziekenhuis.nl., Stevens J; Centre for Human Drug Research, Leiden, 2333 CL, The Netherlands. d.j.touw@umcg.nl., Kamerling IMC; Centre for Human Drug Research, Leiden, 2333 CL, The Netherlands. annekedijkmans@hotmail.com.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2017 Oct 31; Vol. 6 (4). Date of Electronic Publication: 2017 Oct 31.